Preclinical Evaluation of P4B-2412 as Phosphodiesterase 4B Radioligand for Positron Emission Tomography Imaging
Song, Z.; Li, Y.; Feng, S.; Chen, J.; Zhou, X.; Zhang, Z.; Sun, Z.; Rong, J.; Zhao, C.; Chaudhary, A.; Patel, J. S.; Gao, Y.; Collier, T. L.; Ran, C.; Haider, A.; Yuan, H.; Liang, S. H.
Show abstract
Phosphodiesterase 4B (PDE4B) plays a critical role in cAMP hydrolysis and is highly expressed in brain regions associated with neuroinflammation and central nervous system (CNS) disorders. Selective PDE4B radioligands hold significant potential for elucidating disease mechanisms, such as those in Parkinsons disease and schizophrenia, and enabling target occupancy measurements. In this study, we developed [18F]P4B-2412, a novel PDE4B-selective radioligand, and evaluated its utility for positron emission tomography imaging (PET). [18F]P4B-2412 was synthesized in high radiochemical yield (27.2%), excellent radiochemical purity (99%), and favorable molar activity (66.2 {+/-} 2.5 GBq/mol. In vitro autoradiography and dynamic PET imaging demonstrated high specificity for PDE4B in rodent brain regions, with blocking studies confirming negligible interaction with PDE4D. [18F]P4B-2412 also exhibited robust in vitro and in vivo metabolic stability. These results establish [18F]P4B-2412 as a promising PET imaging agent for visualizing PDE4B activity, offering a valuable tool for investigating neuroinflammation and advancing CNS drug development.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Design, synthesis, and characterization of mG2P026 as a high contrast PET imaging ligand for metabotropic glutamate receptor 2 96%
- Development of a chemical probe to enable characterization of the casein kinase 1γ subfamily 94%
- Discovery of The Clinical Candidate S-892216: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19 94%
Similar papers in this journal
- Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2 96%
- Synthesis and preclinical evaluation of MTP38 as a novel PET ligand for phophodiesterase 7 in the brain 95%
- A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: Synthesis and preclinical characterization of SDM-16 94%
Similar papers in this journal
- Development of a PET radioligand for α2δ-1 subunit of calcium channels for imaging neuropathic pain 98%
- Shifting the selectivity of pyridopyrimidin-7(8H)-one inhibitors towards the salt-inducible kinase (SIK) subfamily 93%
- Modulation of endogenous opioid signaling by inhibitors of puromycin sensitive aminopeptidase 93%
Similar papers in this journal
- Stereo-specific Lasofoxifene Derivatives Reveal the Interplay between Estrogen Receptor Alpha Stability and Antagonistic Activity in ESR1 Mutant Breast Cancer Cells 94%
- Discovery of a new class of reversible TEA-domain transcription factor inhibitors with a novel binding mode 92%
- Synthesis and Biological Assessment of Chalcone and Pyrazoline Derivatives as novel inhibitor for ELF3-MED23 Interaction 92%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.